| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 391,277 | 396,701 | 446,828 | | Cost of Revenue | 256,228 | 283,040 | 306,469 | | | Gross Profit | 135,049 | 113,661 | 140,359 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 106,287 | 115,755 | 122,265 | | Non Recurring | 352 | 3,453 | 688 | | Others | 18,741 | 20,391 | 18,084 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 9,669 | (25,938) | (678) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 542 | 316 | 799 | | Earnings Before Interest And Taxes | 10,211 | (25,622) | 121 | | Interest Expense | 123 | 644 | 278 | | Income Before Tax | 10,088 | (26,266) | (157) | | Income Tax Expense | 783 | (360) | (17) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,305 | (25,906) | (140) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 9,305 | (25,906) | (140) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,305 | ($25,906) | ($140) |
|
1.48% Nasdaq 
Income Statement
